In line with its tumor suppressor activity in HCC [35], miR-26a overexpression in HCC cell lines reduced cell viability by influencing ERα, p53 and p21 expression and by inhibiting its known targets, cyclin D2 and cyclin E2 [36]. The gene discussed is TP53; the disease is neoplasm.